Breaking News
Solar And Storage Could Reshape Rural Electricity Markets
FBI Obtains Election Records From Arizona Senate
While COMEX slept, tokenized gold revealed a signal
With World Seemingly At War, DARPA Finds Time To Unveil The X-76
Top Tech News
The Pentagon is looking for the SpaceX of the ocean.
Major milestone by 3D printing an artificial cornea using a specialized "bioink"...
Scientists at Rice University have developed an exciting new two-dimensional carbon material...
Footage recorded by hashtag#Meta's AI smart glasses is sent to offshore contractors...
ELON MUSK: "With something like Neuralink… we effectively become maybe one with the AI."
DARPA Launches New Program Generative Optogenetics, GO,...
Anthropic Outpaces OpenAI Revenue 10X, Pentagon vs. Dario, Agents Rent Humans | #234
Ordering a Tiny House from China, what's the real COST?
New video may offer glimpse of secret F-47 fighter
Donut Lab's Solid-State Battery Charges Fast. But Experts Still Have Questions
DARPA Nucleic Technology Funded to Get Virus Response to 1-60 Days
The P3 teams are developing technologies to deliver antibodies using nucleic acid technology, and achieve sufficient serum concentrations of the antibodies for protection against the pathogen within three days after administration.
DARPA has programs for Pandemic Prevention Platform, Nucleic Acids On-Demand Worldwide (NOW), and PReemptive Expression of Protective Alleles and Response Elements (PREPARE) programs.
Nucleic Acids On-Demand Worldwide (NOW)
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.